samedan logo

 
 
spacer
home > pmps > summer 2017 > the patient is the key
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Patient is the Key

The Parenteral Drug Association’s (PDA’s) conference theme this year will be ‘Improving Patient Outcomes with Innovative Drug Delivery’. With more biologics developed to treat chronic diseases, this title reflects the everincreasing commitment to enhancing the self-injecting experience and improving patient outcomes.

This event aspires to educate attendees on global trends, providing a future outlook on all aspects surrounding pre-filled syringes and injection devices. It will highlight links in the manufacturing chain – from materials and component industries to clinical and patient needs. One focus will be on the overall biotechology sector, while also looking closely at largevolume applications, formulations and biosimilars and advanced therapeutic products.

Three parallel tracks will discuss new uses, challenges and opportunities of patient-to-smart device interactions as they become more significant and sophisticated, thus having an immediate positive effect on patient adherence and therapy outcomes. Questions such as: ‘How can learnings and findings from clinical trials and usability work be incorporated into more patient-friendly delivery systems?’ will be posed and debated.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Ampio’s Phase I Study for Inhaled Ampion Advances to Completing Enrollment of Covid-19 Patients With Respiratory Distress

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today that its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients is proceeding to full open enrollment following clearance by the Safety Monitoring Committee (SMC), which found Ampion to be safe and well-tolerated after reviewing results from the first three treatment groups.
More info >>

White Papers

What You Need To Know About Thermal Shipping Technologies

Temptime Corporation

This paper presents highlights from a thermal performance study conducted by Modality Solutions LLC. The study examined the performance of five shipping technologies commonly used by specialty pharmacies to transport high-value refrigerated specialty medicines against an industry accepted temperature profile standard.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement